Novartis AG (Novartis AG) Purchase Of Investment

: $-750 Mil (TTM As of Dec. 2023)

View and export this data going back to 1996. Start your Free Trial

Novartis AG's purchase of investment for the three months ended in Dec. 2023 was $-573 Mil. It means Novartis AG spent $573 Mil on purchasing investments. Novartis AG's purchase of investment for the trailing twelve months (TTM) ended in Dec. 2023 was $-750 Mil.

Compared with last quarter ($-39 Mil in Sep. 2023 ), Novartis AG spent more money on purchasing investments in Dec. 2023 ($-573 Mil).

Novartis AG Purchase Of Investment Historical Data

The historical data trend for Novartis AG's Purchase Of Investment can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Novartis AG Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Purchase Of Investment

-530.00

-2,130.00

-16,591.00

-34,810.00

-747.00

Novartis AG Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Purchase Of Investment																-10,577.00	-107.00	-31.00	-39.00	-573.00

Novartis AG Purchase Of Investment Calculation

Purchase of Investments represents cash outflow on the purchase of investments in securities.

Purchase Of Investment for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $-750 Mil.

Novartis AG Purchase Of Investment Related Terms

Thank you for viewing the detailed overview of Novartis AG's Purchase Of Investment provided by GuruFocus.com. Please click on the following links to see related term pages.

Novartis AG (Novartis AG) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Novartis AG (NYSE:NVS) » Definitions » Purchase Of Investment

Comparable Companies

Traded in Other Exchanges

NVSEF:USA NVS N:Mexico NOVNz:UK 0QLR:UK NOTA:Germany NOTA:Germany NOVNEE:Switzerland NOVN:Switzerland N1VS34:Brazil NVS:Argentina

Address

Lichtstrasse 35, Basel, CHE, 4056

Website

https://www.novartis.com

Novartis develops and manufactures innovative drugs. The firm's key areas of drug development include oncology, rare diseases, neuroscience, immunology, respiratory, cardio-metabolic, and established medicines. The company sells its products globally, with the United States representing close to one third of total revenue.